Identification
Personal identification
- Full name
- Bruna Velosa Ferreira
Citation names
- Velosa Ferreira, Bruna
Author identifiers
- Ciência ID
- 9916-B8AE-5BE7
- ORCID iD
- 0000-0002-5612-5385
Email addresses
- bruna.ferreira@research.fchampalimaud.org (Professional)
Addresses
- Champalimaud Centre for the Unknown, Largo da Fundação Champalimaud, 1400-038, Lisbon, Lisboa, Portugal (Professional)
Websites
Knowledge fields
- Medical and Health Sciences - Clinical Medicine
- Medical and Health Sciences - Clinical Medicine - Hematology
- Medical and Health Sciences - Basic Medicine
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
Spanish; Castilian | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | |
English | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | |
Dutch | Beginner (A1) | Beginner (A1) | Beginner (A1) | Beginner (A1) | |
Portuguese | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) |
Education
Degree | Classification | |
---|---|---|
2015/10 - 2022/03/04
Concluded
|
Doutoramento em Medicina (Doutoramento)
Major in Investigação Clínica - Hematoncologia, Multiple Myeloma
Universidade Nova de Lisboa, Portugal
"The role of extracellular vesicles in Multiple Myeloma" (THESIS/DISSERTATION)
|
Aprovado com Distinção e Louvor |
2019/04/08
Concluded
|
Course on Multiple Myeloma (Outros)
Hospital Universitario de Salamanca, Spain
|
|
2011 - 2019
Concluded
|
Médica especialista (Título de especialista)
Major in Hematologia Clínica
Centro Hospitalar de Lisboa Ocidental EPE, Portugal
|
|
2018/11/15
Concluded
|
2nd Flow Cytometry Course (Outros)
Instituto Gulbenkian de Ciência, Portugal
|
|
2016 - 2017
Concluded
|
Doutoramento em Medicina (Curso de doutoramento (conclusão de unidades curriculares))
Major in Investigação Clínica
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal
|
18 |
2017
Concluded
|
Course on Rodent Anaesthesia & Surgery (Outros)
Fundação Champalimaud, Portugal
|
|
2016
Concluded
|
Course on Laboratory Animal Science (Outros)
Fundação Champalimaud, Portugal
|
|
2014
Concluded
|
Curso de Investigação Clínica e Publicação Científica (Outros)
Centro Hospitalar de Lisboa Ocidental EPE, Portugal
|
|
2012
Concluded
|
Myeloproliferative Neoplasms Preceptorship (Outros)
Guys and St. Thomas Hospital, NHS, United Kingdom
|
|
2002 - 2008/06/22
Concluded
|
Medical Degree (Licenciatura)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"n/a" (THESIS/DISSERTATION)
|
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2016 - Current | Researcher (Research) | Fundação Champalimaud, Portugal |
Other Careers
Category Host institution |
Employer | |
---|---|---|
2021/06 - Current | Assistente (Médica) | Centro Champalimaud, Portugal |
Chamapalimaud Clinical Centre - Hemato-Oncology Unit , Portugal | ||
2011 - 2019 | Interno (Médica) | Centro Hospitalar de Lisboa Ocidental EPE, Portugal |
2013 - 2014 | Interno (Médica) | Guys and St. Thomas Hospital, NHS, United Kingdom |
General Medical Council, United Kingdom | ||
2010/01 - 2010/12 | Interno (Médica) | Hospital do Espírito Santo de Évora, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2019/09/22 - 2020/02/18 | Maternity Leave 2 | Ministério do Trabalho Solidariedade e Segurança Social, Portugal |
2017/07/16 - 2017/09/29 | Maternity Leave 1 | Ministério do Trabalho Solidariedade e Segurança Social, Portugal |
2009/01 - 2009/12 | Colaborador | Instituto Português do Sangue e da Transplantação IP, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2018 - 2019 | O papel do microambiente metastático no mieloma múltiplo extramedular
Principal investigator
Fundação Champalimaud, Portugal
|
Sociedade Portuguesa de Hematologia
Ongoing
|
Contract
Designation | Funders | |
---|---|---|
2024 - Current | International clinical trial: EPCORE (M22-003)
.
Researcher
|
|
2024 - Current | International clinical trial: MAJESTEC-7 (MMY3005)
.
Researcher
|
|
2024 - Current | International clinical trial: CERVINO (M22-574)
.
Researcher
|
|
2024 - Current | International clinical trial: BELLWAVE-011 (MK1026-011)
.
Researcher
|
|
2023 - Current | International clinical trial: IMPACTMF
.
Researcher
|
|
2023 - Current | International clinical trial: WAVELINE (MK2140-006)
.
Researcher
|
|
2023 - Current | International clinical trial: SUCCESSOR-1 (CA057-001)
.
Researcher
|
|
2023 - Current | International clinical trial: MAJESTEC-9 (MMY3006)
.
Researcher
|
|
2023 - Current | International clinical trial: ACT17453
.
Researcher
|
|
2022 - Current | International clinical trial: EXCALIBER
.
Researcher
|
|
2022 - Current | International clinical trial: ESCALADE
.
Researcher
|
|
2021 - Current | International clinical trial: LOXO-BTK-20019
.
Researcher
|
|
2021 - 2024 | Combined immUNotherapeutIC approach for targeting bone marrow microenvironment in Multiple Myeloma
PTDC/MED-ONC/1215/2021
Researcher
Fundação Champalimaud, Portugal
|
Concluded
|
2017 - 2022 | The role of metastatic microenvironment in Multiple Myeloma extramedullary disease (EMphAsIS)
PTDC/MEC-HEM/30315/2017
Researcher
Fundação Champalimaud, Portugal
|
Ongoing
|
2019 - 2021 | Zebrafish avatar for CLL therapy screening
Kickstarters 2019
Researcher
Fundação Champalimaud, Portugal
|
Fundação Champalimaud
Ongoing
|
2015 - 2015 | International clinical trial: PIANO-CML II
CAMN107APT05
Researcher
|
Concluded
|
2013 - 2014 | International clinical trial: PrefMad
NCT01724021
Researcher
|
|
2012 - 2014 | National database: PTI Report
.
Researcher
|
Concluded
|
Outputs
Publications
Book chapter |
|
Conference abstract |
|
Conference poster |
|
Journal article |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2024 | Delivered an oral communication summarizing the most significant findings from ASH 2024 in the field of multiple myeloma. Her presentation provided an expert overview of key advances, including novel therapeutic strategies and groundbreaking research that may impact clinical practice. Through this session, she contributed to the dissemination of critical scientific knowledge, reinforcing the importance of translating research into improved patient care. | Hematology Connected |
2024 | A Prática Clínica Atual com Carfilzomib | Simpósio na SPH |
2023 | Junior Lecture - Mieloma Múltiplo - Inovações terapêuticas. | Annual Meeting of the Portuguese Society of Hematology
Portuguese Society of Hematology
|
2023 | During the event, she addressed questions from patients and their families, providing valuable insights into the management and treatment of multiple myeloma. This was her first time participating in such an event, where she represented the Portuguese Multiple Myeloma Group. |
Dr. Bruna Ferreira participated in the Multiple Myeloma Seminar organized by the APCL (Portuguese Association Against Leukemia)
in collaboration with the International Myeloma Foundation.
|
2022 | Extracellular vesicle proteins as new biomarkers in multiple myeloma patients: a real-world study. | 30ª Sabatina de Hematologia |
2018 | Characterization of Circulating and Bone Marrow Derived Exosomes in Multiple Myeloma Patients | 60th American Hematology Association Annual Meeting, San Diego December 2018.
American Hematology Association (San Diego December, United States)
|
2018 | Myeloma Patients-derived exosomes as a potential new clinical tool | 3rd International Congress of CiiEM Research and Innovation in Human and Health Sciences |
2014/10/24 | Post transplant ruxolitinib? - Mielofibrose diagnóstico e tratamento | Reunião de discussão de casos clínicos
Novartis (Lisboa, Portugal)
|
2014 | Transplante alogénico de precursores hematopoiéticos em anemia aplásica grave | Reunião Anual da Sociedade Portuguesa de Hematologi
Sociedade Portuguesa de Hematologi (Portugal)
|
2013/03/22 | Leucemia mielóide aguda secundária a anemia refractária com excesso de blastos no idoso com resposta a 5 azacitidina | Active tailored therapy on MDS sessions sharing best practices
Celgene (Lisboa, Portugal)
|
2012/09/22 | Clinical cases session on ITP and treatment with thrombopoietin receptor agonists | Visit to Reference Center in ITP
Amgen
|
2012 | Caracterização epidemiológica da PTI em Portugal - análise intermédia | Reunião Anual da Sociedade Portuguesa de Hematologia
Sociedade Portuguesa de Hematologia
|
2011 | A acuidade dos scores na estratificação de risco precoce do doente internado | Congresso Nacional de Medicina Interna
Sociedade Portuguesa de Medicina Interna (Portugal)
|
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2024 - Current | Participated in the National Conference of the Portuguese Association Against Leukemia (APCL). This annual event brought together healthcare professionals, patients, caregivers, and stakeholders in the field of hemato-oncology to share knowledge and experiences. Dr. Ferreira contributed to the panel "What We Would Like to Know About Blood Cancers: MDS, Myeloproliferative Neoplasms, and Multiple Myeloma," discussing the latest advances and challenges in the treatment of these diseases | National Conference of the Portuguese Association Against Leukemia (APCL) |
2023 - Current | Formação em Biovigilância - Tecidos e Células | |
2016 - 2017 | European Hematology Association Master Class - 2016/2017 Online problem-based programme for problem solving related to complex
and challenging cases presented by international experts
Workshop
|
European Hematology Association, Netherlands
|
2014/11/06 - 2014/11/07 | 1o Curso Sobreviventes de Doenças Oncológicas, Instituto Português de Oncologia de Lisboa Francisco Gentil, 6 a 7 novembro 2014 | Curso Sobreviventes de Doenças Oncológicas |
2013/02/14 - 2013/02/15 | Advanced Workshop on Myelodysplastic Syndromes, Heinrich Heine Universitat
Dusseldorf, 14 a 15 feveiro 2013
Workshop
|
Advanced Workshop on Myelodysplastic Syndromes
Heinrich-Heine-Universität Düsseldorf, Germany
|
Association member
Society Organization name | Role | |
---|---|---|
2011 - Current | Sociedade Portuguesa de Hematologia | |
2011 - Current | European Hematology Association | |
2008 - Current | Ordem do Médicos | Cédula Profissional |
2013 - 2014 | General Medical Council Full License to Practice |
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2023 - Current | Policitemia Vera and Chronic Myeloide Leukemia - 2ª edição do curso 'Exame Final de Hematologia' do Dioscope Learning Center.Dioscope | ||
2022 - Current | Policitemia Vera and Chronic Myeloide Leukemia - 1ª edição do curso 'Exame Final de Hematologia' do Dioscope Learning Center.Dioscope | ||
2024 - 2024 | LMC: Abordagem diagnóstica e fatores prognósticos - 3º Módulo do Curso de Neoplasias Mieloides Crónicas on behalf of the Portuguese Group of Myeloproliferative Neoplasms | (Outros) | |
2018/05/27 - 2018/05/28 | Curso Patologia Médica da Grávida - Curso pós congreso 21 Congresso Nacional de Medicina Interna | Curso pós-congresso: Patologia Médica da Grávida (Outros) | |
2013/01/21 - 2013/01/21 | Trombocitopenia grave num doente no SU | Sessão de Formação em Serviço | Centro Hospitalar de Lisboa Ocidental EPE, Portugal |
2012/06/11 - 2012/06/11 | Síndrome febril indeterminado num doente com linfoma | Sessão de Formação em Serviço | Centro Hospitalar de Lisboa Ocidental EPE, Portugal |
Interview (tv / radio show)
Program | Topic | |
---|---|---|
2024 - Current | Fact Check da Saúde (Season 2, Episode 7) on Saúde+ TV. In this episode, she contributed her expertise as a clinical hematologist, discussing key topics related to hematologic diseases, patient care, and advancements in medical research. The discussion aimed to clarify misconceptions, provide accurate medical information, and highlight the importance of innovation in hematology. |
Mentoring / Tutoring
Topic | Student name | |
---|---|---|
2011 - 2015 | Supervision of medicine students and medical interns | . |
Distinctions
Award
2022 | PRÉMIO JOSÉ EDUARDO GUIMARÃES Melhor trabalho em Hematologia
Centro Hospitalar Universitário de São João, Portugal
|
2022 | Prémio melhor Poster na 30ª Sabatina de Hematologia |
2019 | Gilead Génese, as Co-investigator
Gilead Sciences, France
|
2018 | Bolsa de Iniciação à Investigação, as Principal Investigator
Sociedade Portuguesa de Hematologia, Portugal
|
2016 | Registration Grant for the European Hematology Association 21th Congress
European Hematology Association, Netherlands
|